Sign Up for Our E-Newsletter

A Survivor and Advocate’s Take on BIO Summit 2015

Posted on November 5, 2015


I’ve lost four friends to colon cancer this year and I’m afraid I’ll lose more before the year is out. While we have effective treatments for some, we still lose far too many to this disease. I wanted to know what I could do as a survivor and patient advocate to make a difference, so I went to Bio Summit 2015 to find out.

Read more

Top 6: Need to Know About EGFR Inhibitors Rash Management

Posted on November 3, 2015


Our Conversations Webinar Series is an opportunity to link national experts in colorectal cancer and other related fields to you, right in the comfort of your own home. The programs are designed to empower you to play a leading role in you healthcare management.

Some of the most common side effects we hear about from metastatic colorectal cancer patients on Epidermal Growth Factor Receptor Inhibitors (EGFRI), such as Erbitux (also known as Cetuximab) and Vectibix (also known as Panitumumab), are dry skin, acne and rashes, so on October 21, we hosted our Conversations Webinar “EGFR Inhibitors Rash Management: Prevention Is Key.”

Did you miss the webinar? No problem! Check out these top 6 takeaways and watch the replay.

Read more

FDA UPDATE as of 11/3/15 — Promising Drug from ASCO Now Accepting Applicants for New Study

Posted on November 3, 2015


FDA UPDATE as of November 3, 2015 – Merck has just announced that the FDA has given pembrolizumab (Keytruda) breakthrough status, which will speed up the development and review for FDA approval. The update was a result of the findings in the ongoing phase II study, which demonstrated high response rates with pembrolizumab in patients with heavily pretreated colorectal cancer with a specific type of tumor. In addition to the phase II study, Merck is planning to launch a phase III trial. We will continue to keep you updated as more details emerge.

Dr. Laura detailed the results of the phase II study that was presented at ASCO this summer back in June. Read more

Volunteer of the Quarter: Steve Godri

Posted on October 27, 2015

Steve Godri

We continue to be inspired by the hundreds of volunteers spearheading efforts to put colon cancer on the map and changing the face of this disease. That’s why we started the Volunteer of the Quarter feature, which honors some of our most passionate, dedicated volunteers.

This quarter we’re celebrating Steve Godri, who, along his family, started Steph’s Fall 5K in honor of his sister Stephanie Godri-Johnston, who passed away from colon cancer in 2012 at just 32. To celebrate Stephanie’s love of cross country running and help people in need get screened for colon cancer, proceeds from the annual run/walk help fund the Stephanie Godri-Johnston Memorial Scholarship, as well as our Blue Hope Financial Assistance program (in four years, the Godri family has raised $15,000 in support of this important program). Learn more about Steve, Steph’s Fall 5K and his advice for anyone looking to honor a loved one.

Read more

Understanding SIR-Spheres Y-90 Resin Microspheres

Posted on October 23, 2015


If you or a loved one have recently been diagnosed with colorectal cancer that has metastasized to the liver, it is important to understand the options for treatment.

Read more